Ali Amid

Overview: Dr. Amid received his medical degree from the Tehran University of Medical Sciences and completed his pediatric residency at the University of Calgary, followed by his pediatric hematology/oncology fellowship at the University of Ottawa and University of Toronto. Dr. Amid subsequently completed a clinical and research fellowship in hemoglobinopathies and iron overload disorders at the Hospital for Sick Children (SickKids) in Toronto. Prior to moving to Vancouver and starting his current role as a Pediatric Hematologist at BC Children’s Hospital in 2021, he was an Assistant Professor of Pediatrics at the University of Ottawa and a Pediatric Hematologist at Children’s Hospital of Eastern Ontario.
A BCCH, he is the Director of the Hemoglobinopathy and Iron Overload Clinic.
Publications: Monolobated megakaryocytes in Diamond–Blackfan anemia with RPL5 mutation at disease presentation mimicking myelodysplastic syndrome
Pediatric Blood & Cancer
Audi Setiadi and Claudia Singh and Amanda Li and Nicholas Au and Ali Amid
DOI: 10.1002/pbc.30771
11/2023
Rivaroxaban for Management of Venous Thromboembolism in Pediatric Nephrotic Syndrome; a Case Report and Review of Literature
Pediatric Hematology and Oncology
Marie-Claude Pelland-Marcotte and Soumitra Tole and Eve Bouhelier and Susan Lee and Jessica Halparin and Cherry Mammen and Karen Lyons and Ali Amid
DOI: 10.1080/08880018.2022.2150797
10/2023
Monolobated Megakaryocytes in Diamond Blackfan Anemia with RPL5 Mutation at Disease Presentation Mimicking Myelodysplastic Syndrome
Audi Setiadi and Claudia Singh and Amanda Li and Nicholas Au and Ali Amid
DOI: 10.22541/au.169468925.50466482/v1
09/2023
Moyamoya vasculopathy in hemoglobin H Constant Spring: Epidemiological coincidence or pathological consequence?
Pediatric Blood & Cancer
Rozalyn Chok and Jad El Maamari and Heather McCartney and Ali Amid
DOI: 10.1002/pbc.30236
06/2023
Optimizing transfusion therapy for survivors of Haemoglobin Bart's hydrops fetalis syndrome: Defining the targets for haemoglobin-H fraction and “functional” haemoglobin level
British Journal of Haematology
Ali Amid and Nick Barrowman and Isaac Odame and Melanie Kirby-Allen
DOI: 10.1111/bjh.18077
05/2022
Consensus statement for the perinatal management of patients with a thalassemia major
Blood Advances
Tippi C. MacKenzie and Ali Amid and Michael Angastiniotis and Craig Butler and Sandra Gilbert and Juan Gonzalez and Roberta L. Keller and Sandhya Kharbanda and Melanie Kirby-Allen and Barbara A. Koenig and Wade Kyono and Ashutosh Lal and Billie R. Lianoglou and Mary E. Norton and Keith K. Ogasawara and Tachjaree Panchalee and Mara Rosner and Marisa Schwab and Alexis Thompson and John S. Waye and Elliott Vichinsky
DOI: 10.1182/bloodadvances.2021005916
12/2021
Immune tolerance induction using Fc-fusion-protein recombinant factor IX in severe haemophilia B
Haemophilia
Ali Amid and Heather Perkins and Julie Gauthier and Arnaud Bonnefoy and Manuel Carcao and Georges-Étienne Rivard and Robert J. Klaassen
DOI: 10.1111/hae.14424
11/2021
Outcomes of haemoglobin Bart’s hydrops fetalis following intrauterine transfusion in Ontario, Canada
Archives of Disease in Childhood - Fetal and Neonatal Edition
Hui Jue Zhang and Ali Amid and Laura A Janzen and Catherine I Segbefia and Shiyi Chen and Uma Athale and Karen Charpentier and Manuela Merelles-Pulcini and Gareth Seaward and Edmond N Kelly and Isaac Odame and John S Waye and Greg Ryan and Melanie Kirby-Allen
DOI: 10.1136/archdischild-2019-317626
01/2021
Dabigatran etexilate for the treatment of acute venous thromboembolism in children (DIVERSITY): a randomised, controlled, open-label, phase 2b/3, non-inferiority trial.
The Lancet. Haematology
DOI: 10.1016/s2352-3026(20)30368-9
PubMed: 33290737
12/2020
Drisapersen associated with elevated serum factor VIII levels in Duchenne muscular dystrophy
Neurology
DOI: 10.1212/wnl.0000000000009139
03/2020
Safety of dabigatran etexilate for the secondary prevention of venous thromboembolism in children.
Blood
DOI: 10.1182/blood.2019000998
PubMed: 31805182
02/2020
Outcomes and risk factors of massive and submassive pulmonary embolism in children: a retrospective cohort study.
The Lancet. Haematology
DOI: 10.1016/s2352-3026(18)30224-2
PubMed: 30772417
02/2019
Mild Hereditary Spherocytosis without Accompanying Hereditary Haemochromatosis: An Unrecognised Cause of Iron Overload
Acta Haematologica
Soumitra Tole and Ali Amid and Jillian Baker and Kevin Kuo and Jakob Pugi and Manuel Carcao
DOI: 10.1159/000497175
2019
Iron overload in transfusion-dependent survivors of hemoglobin Bart's hydrops fetalis.
Haematologica
DOI: 10.3324/haematol.2017.178368
01/2018
An international registry of survivors with Hb Bart's hydrops fetalis syndrome.
Blood
DOI: 10.1182/blood-2016-08-697110
03/2017
Optimizing chronic transfusion therapy for survivors of hemoglobin Barts hydrops fetalis
Blood
Ali Amid and Shiyi Chen and William Brien and Melanie Kirby-Allen and Isaac Odame
DOI: 10.1182/blood-2015-10-673889
03/2016
Optimizing chronic transfusion therapy for survivors of hemoglobin Barts hydrops fetalis
Blood
DOI: http://dx.doi.org/10.1182/blood-2015-10-673889
2016
Thalassaemia in children: From quality of care to quality of life
Archives of Disease in Childhood
Amid, A. and Saliba, A.N. and Taher, A.T. and Klaassen, R.J.
DOI: 10.1136/archdischild-2014-308112
2015
Presentation of Central Nervous System Tumours
Pediatric Neuro-Oncology
2015
Screening for thalassemia carriers in populations with a high rate of iron deficiency: Revisiting the applicability of the mentzer index and the effect of iron deficiency on Hb A2 levels
Hemoglobin
Amid, A. and Haghi-Ashtiani, B. and Kirby-Allen, M. and Haghi-Ashtiani, M.T.
DOI: 10.3109/03630269.2015.1024321
2015
Hb S/ß⁺-thalassemia due to Hb sickle and a novel deletion of dnase I hypersensitive sites HS3 and HS4 of the ß locus control region
Haematologica
Amid, A. and Cheong, M. and Eng, B. and Hanna, M. and Hohenadel, B.-A. and Nakamura, L.M. and Walker, L. and Odame, I. and Kirby-Allen, M. and Waye, J.S.
DOI: 10.3324/haematol.2014.117408
2015
Improving outcomes in children with sickle cell disease: Treatment considerations and strategies
Pediatric Drugs
Amid, A. and Odame, I.
DOI: 10.1007/s40272-014-0074-4
2014
Risk factors for hyperferritinemia secondary to red blood cell transfusions in pediatric cancer patients
Pediatric Blood and Cancer
Amid, A. and Barrowman, N. and Vijenthira, A. and Lesser, P. and Mandel, K. and Ramphal, R.
DOI: 10.1002/pbc.24629
2013
Evans syndrome secondary to HIV infection
Journal of Pediatric Hematology/Oncology
Amid, A. and Leung, E.
DOI: 10.1097/MPH.0b013e3182a05a93
2013
Impact of radiation avoidance on survival and neurocognitive outcome in infant medulloblastoma
Current Oncology
Lafay-Cousin, L. and Bouffet, E. and Hawkins, C. and Amid, A. and Huang, A. and Mabbott, D.J.
2009
Thalassemia in Iran: Epidemiology, prevention, and management
Journal of Pediatric Hematology/Oncology
Abolghasemi, H. and Amid, A. and Zeinali, S. and Radfar, M.H. and Eshghi, P. and Rahiminejad, M.S. and Ehsani, M.A. and Najmabadi, H. and Akbari, M.T. and Afrasiabi, A. and Akhavan-Niaki, H. and Hoorfar, H.
DOI: 10.1097/MPH.0b013e3180437e02
2007
International medical response to a natural disaster: Lessons learned from the bam earthquake experience
Prehospital and Disaster Medicine
Abolghasemi, H. and Radfar, M.H. and Khatami, M. and Nia, M.S. and Amid, A. and Briggs, S.M.
DOI: 10.1017/S1049023X00003599
2006
Clinical quiz
Journal of Pediatric Gastroenterology and Nutrition
Abolghasemi, H. and Kavehmanesh, Z. and Matinzadeh, Z.K. and Amid, A. and Ahmadi, M.
2005
Factor XIII deficiency in south-east Iran
Haemophilia
Eshghi, P. and Abolghasemi, H. and Sanei-Moghaddam, H. and Anwar, R. and Jazebi, M. and Amid, A. and Ala, F.A.
DOI: 10.1111/j.1365-2516.2004.00951.x
2004
An update on the prevalence of glucose-6-phosphate dehydrogenase deficiency and neonatal jaundice in Tehran neonates
Clinical Biochemistry
Abolghasemi, H. and Mehrani, H. and Amid, A.
DOI: 10.1016/j.clinbiochem.2003.11.010
2004
Research: Current Projects
Dr. Amid’s area of clinical and research interest is in the field of thalassemia, sickle cell disease, iron overload, and thrombosis, and he collaborates with other researchers on a national and international level. He is the principal investigator of an international collaborative research study in thalassemia (IntercontinenTHAL study), and a member of the Hemoglobin Bart’s Hydrops Fetalis Consortium and the International Pediatric Thrombosis Network. He has participated in numerous academic and registered clinical trials.

Honours & Awards

Dr. Amid has been the recipient of many research and clinical awards (e.g. Thalassemia Foundation of Canada Research Grant) and his research has been published in leading hematology journals like Blood, Lancet Haematology and Haematologica.

Stories See all

A safer treatment path for high-risk children to overcome food allergies

New research from BC Children’s Hospital Research Institute and UBC reveals a safe path to overcoming food allergies for older children or building resistance for those who can’t risk consuming allergens. It’s called sublingual immunotherapy (SLIT), and it involves placing small amounts of food allergens under the tongue.

Continue reading A safer treatment path for high-risk children to overcome food allergies

Government of Canada invests $20 million to improve health outcomes of children living with rare diseases

The Government of Canada is providing $20 million over five years for the creation of RareKids-CAN: Pediatric Rare Disease Clinical Trials and Treatment Network. This national network, of which BCCHR will be a part, will support national and international clinical trials to advance discoveries, enable better prevention, diagnosis, and treatments, to improve health outcomes for children and adolescents affected by rare diseases.

Continue reading Government of Canada invests $20 million to improve health outcomes of children living with rare diseases

New study shows the potential of new treatment strategies for most common childhood cancer

Researchers made a key discovery about how childhood acute lymphoblastic leukemia (ALL) evolves and responds to targeted therapies suggesting that clinicians can start looking for precision treatments for a child’s cancer immediately after diagnosis, rather than waiting until the cancer has come back.

Continue reading New study shows the potential of new treatment strategies for most common childhood cancer

Study reveals surprising link between malnutrition and rising antibiotic resistance

A new study by Dr. Paula Littlejohn discovers the connection between a lack of crucial micronutrients and the composition of gut microbiomes that could increase antibiotic resistance.

Continue reading Study reveals surprising link between malnutrition and rising antibiotic resistance

Donate to Research

We believe there’s nothing we can’t do with your support. It can take years to turn scientific breakthrough into new interventions and treatments. Funding helps speed the pace of change. When given the resources, we can bring transformative therapies – and hope – out of the laboratory and into the clinic to save and improve children’s lives.

Give Now